Globe Newswire (Mon, 23-Mar 9:15 AM ET)
SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC Foot & Ankle Implant
Globe Newswire (Thu, 19-Mar 7:30 AM ET)
Globe Newswire (Wed, 18-Feb 8:30 AM ET)
Globe Newswire (Thu, 29-Jan 9:00 AM ET)
SINTX Technologies Sees Massive Pre-Market Surge Following Patent Issuance
Market Chameleon (Wed, 19-Feb 3:40 AM ET)
SINTX Technologies Inc is an advance ceramics company that develops, manufactures, and commercializes silicon nitride biomaterials, composites, devices, and related technologies for medical and other high-value applications. It provides biomedical solutions for medical devices specializing in silicon nitride (Si3N4) for musculoskeletal and antipathogenic applications. It also manufactures silicon nitride parts for customers in the electrical, aerospace, and other industrial sectors. The company is a globalised leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans. The Company operates as one operating segment.
Sintx Technologies trades on the NASDAQ stock market under the symbol SINT.
As of April 16, 2026, SINT stock price declined to $2.68 with 26,965 million shares trading.
SINT has a beta of 2.63, meaning it tends to be more sensitive to market movements. SINT has a correlation of 0.18 to the broad based SPY ETF.
SINT has a market cap of $11.05 million. This is considered a Sub-Micro Cap stock.
Last quarter Sintx Technologies reported $290,000 in Revenue and -$.36 earnings per share. This fell short of revenue expectation by $-50,000 and exceeded earnings estimates by $.19.
In the last 3 years, SINT traded as high as $438.00 and as low as $1.71.
The top ETF exchange traded funds that SINT belongs to (by Net Assets): VXF, DCOR.
SINT has outperformed the market in the last year with a return of +54.9%, while the SPY ETF gained +34.9%. However, in the most recent history, SINT shares have underperformed the stock market with its stock returning -28.3% in the last 3 month period and +6.3% for the last 2 week period, while SPY has returned +1.7% and +7.0%, respectively.
SINT support price is $2.56 and resistance is $2.92 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SINT shares will trade within this expected range on the day.